Sun, Dec 21, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Private Equity Strategies

New Ventures: SEB Venture Capital invests in 3D graphics business

Tuesday, July 23, 2013

By: Bailey McCann, Private Equity Strategies

The venture capital arm of SEB, the Northern European financial Group is getting into 3D with a new transaction. SEB Venture Capital has invested in Donya Labs AB, a global leader in optimization of 3D graphics for computer games. The new capital will enable accelerated growth and diversification towards computer-aided design (CAD), architecture and film.

SEB Venture Capital has been investing in venture capital transactions for the past 18 years. With a capital base of SEK 2.5bn, it currently has 28 portfolio companies within technology and life science and has completed 70 exits since inception.

“We already have an investment in this segment, that produces 2D and 3D graphics. So, we are quite familiar with the market, and we think that the market will grow including 3D printing especially in areas like CAD,” says Ulf Lewander, Investment Manager, SEB Venture Capital, in an interview with Private Equity Strategies.

Donya Labs AB has developed unique software called Simplygon, to automatically optimize advanced 3D graphics. Traditionally, optimization of 3D graphics has been expensive and time consuming as a manual process. By automatically optimizing 3D graphics for applications such as real-time visualization, interactivity and 3D printing, workflows can be streamlined and integrated.

“We believe the new business model which operates a cloud version of the technology will open a huge market opportunity,” Lewander says. “Right now the company only sells licensing to high end gaming companies. Those companies pay thousands of dollars per license, per game. We have been able to prove that one 3D model at a time done on the cloud is also justifiable.”

SEB Venture Capital has subscribed to a new share issue of SEK 10m focused on growing this cloud offer and adding new geographies to the company’s footprint. SEB and Donya Labs will be looking for additional subscribers in for a serial round B in the future.

Lewander notes that SEB Venture Capital is focused on finding companies like this that can move from one niche to a broader market. “We are looking for companies that have already proven themselves in tough spaces, going forward we think that will be mostly in software, not hardware.”

 
This article was published in Opalesque's Private Equity Strategies our monthly research update on the global private equity landscape including all sectors and market caps.
Private Equity Strategies
Private Equity Strategies
Private Equity Strategies
Private Equity Strategies


Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. Opalesque Exclusive: U.S. legal receivables fund launched in August[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Investing in asset-backed receivables is a strategy that has been an integral part of the alternative investment space within the overall fixed income asset c

  5. Comment - High fees and low performance hit hedge funds[more]

    From FT.com: Disenchantment over high fees and lackluster performance may finally be turning the tide against hedge funds, fresh data suggest. Despite generally weak returns since the global financial crisis, hedge funds have enjoyed positive net inflows every year since 2010. This helped assets und